• 1
    Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: a consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525541.
  • 2
    Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics—2010 update. A report from the American Heart Association. Circulation. 2009;109 doi; 10.1161/CIRCULATIONAHA, 109.192667.
  • 3
    Ferdinand KC, Ferdinand DP. Race-based therapy for hypertension: possible benefits and potential pitfalls. Expert Rev Cardiovasc Ther. 2008;6:13571366.
  • 4
    Ferdinand KC, Ferdinand DP. Cardiovascular disease disparities: racial/ethnic factors and potential solutions. Curr Cardiovasc Risk Rep. 2009;3:187193.
  • 5
    Flack JM, Kountz DS, Jamerson KA. BP lowering and cardiovascular risk reduction: updated ISHIB consensus statement. Poster presented at American Society of Hypertension 23rd Annual Scientific Meeting; May 14–17, 2008; New Orleans, LA.
  • 6
    Cooper RS, Wolf-Maier K, Luke A, et al. An international comparative study of blood pressure in populations of European vs. African descent. BMC Med. 2005;3:2.
  • 7
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:29812997.
  • 8
    Jamerson K, Weber MA, Bakris GL, et al., the ACCOMPLISH trial investigators benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:24172428.